SCHEMBL7382680

SCHEMBL7382680

CCCc1cc(-c2ccc(Cn3c(-c4ccccc4)nc(Cl)c3C=O)cc2)c(NS(=O)(=O)C(=O)OC(C)(C)C)s1

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ MAS1 P04201 1/20 0.47
▸ AGTR2 P50052 4/20 0.41
▸ EDNRA P25101 4/20 0.38
▸ AGTR1 P30556 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7383678 0.91 MAS1 (0.55) MAS1AGTR2AGTR1
SCHEMBL3975298 0.89 AGTR2 (0.48) MAS1AGTR2AGTR1
SCHEMBL6185055 0.87 MAS1 (0.46) MAS1AGTR2EDNRAAGTR1
SCHEMBL4106849 0.85 MAS1 (0.60) MAS1AGTR2EDNRAAGTR1
SCHEMBL3902365 0.82 MAS1 (0.55) MAS1AGTR2AGTR1
SCHEMBL3903957 0.82 MAS1 (0.56) MAS1AGTR2AGTR1
SCHEMBL4106426 0.81 MAS1 (0.59) MAS1AGTR2EDNRAAGTR1
SCHEMBL4110594 0.79 MAS1 (0.58) MAS1AGTR2EDNRAAGTR1
SCHEMBL6183402 0.78 MAS1 (0.54) MAS1AGTR2AGTR1
SCHEMBL24637548 0.77 AGTR2 (0.61) MAS1AGTR2AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1185527-A1 1-(P-THIENYLBENZYL)-IMIDAZOLES AS ANGIOTENSIN-(1-7) RECEPTOR AGONISTS, METHOD FOR THE PRODUCTION AND THE UTILIZATION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS Aventis Pharma Deutschland GmbH (DE) 2002-03-13 — — EP disclosed
WO-2000068226-A1 1-(P-THIENYLBENZYL)-IMIDAZOLES AS ANGIOTENSIN-(1-7) RECEPTOR AGONISTS, METHOD FOR THE PRODUCTION AND THE UTILIZATION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-11-16 — — WO disclosed
Send feedback